ATE452973T1 - Genetische veränderung von somatischen zellen und deren verwendungen - Google Patents

Genetische veränderung von somatischen zellen und deren verwendungen

Info

Publication number
ATE452973T1
ATE452973T1 AT00907792T AT00907792T ATE452973T1 AT E452973 T1 ATE452973 T1 AT E452973T1 AT 00907792 T AT00907792 T AT 00907792T AT 00907792 T AT00907792 T AT 00907792T AT E452973 T1 ATE452973 T1 AT E452973T1
Authority
AT
Austria
Prior art keywords
somatic cells
genetic modification
cells
genetically modified
loci
Prior art date
Application number
AT00907792T
Other languages
English (en)
Inventor
Alan Colman
Angelika Elisabeth Schnieke
Alexander Jarvis Kind
David Lee Ayares
Yifan Dai
Original Assignee
Revivicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905033.8A external-priority patent/GB9905033D0/en
Priority claimed from GBGB9917023.5A external-priority patent/GB9917023D0/en
Priority claimed from US09/475,674 external-priority patent/US20020012660A1/en
Application filed by Revivicor Inc filed Critical Revivicor Inc
Application granted granted Critical
Publication of ATE452973T1 publication Critical patent/ATE452973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L41/00—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks
    • H04L41/02—Standardisation; Integration
    • H04L41/0213—Standardised network management protocols, e.g. simple network management protocol [SNMP]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L41/00—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks
    • H04L41/22—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks comprising specially adapted graphical user interfaces [GUI]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Signal Processing (AREA)
  • Biophysics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Human Computer Interaction (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00907792T 1999-03-04 2000-03-03 Genetische veränderung von somatischen zellen und deren verwendungen ATE452973T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9905033.8A GB9905033D0 (en) 1999-03-04 1999-03-04 Methods
GBGB9917023.5A GB9917023D0 (en) 1999-07-20 1999-07-20 Methods
US09/475,674 US20020012660A1 (en) 1999-03-04 1999-12-30 Method of preparing a somatic cells for nuclear transfer
PCT/GB2000/000778 WO2000051424A2 (en) 1999-03-04 2000-03-03 Genetic modification of somatic cells and uses thereof

Publications (1)

Publication Number Publication Date
ATE452973T1 true ATE452973T1 (de) 2010-01-15

Family

ID=27269662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00907792T ATE452973T1 (de) 1999-03-04 2000-03-03 Genetische veränderung von somatischen zellen und deren verwendungen

Country Status (11)

Country Link
EP (2) EP2199392A3 (de)
JP (2) JP2002537785A (de)
AT (1) ATE452973T1 (de)
AU (1) AU780754B2 (de)
CA (1) CA2361943C (de)
DE (1) DE60043578D1 (de)
DK (1) DK1159415T3 (de)
ES (1) ES2338631T3 (de)
NZ (1) NZ514620A (de)
PT (1) PT1159415E (de)
WO (1) WO2000051424A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074983B2 (en) 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US7414170B2 (en) 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7253334B2 (en) 2000-12-22 2007-08-07 Aurox, Llc Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
JP3842597B2 (ja) 2001-08-14 2006-11-08 家畜受精卵移植技術研究組合 Ｇ１期細胞の収集方法及び該細胞を用いた核移植方法
AU2003220119A1 (en) 2002-03-07 2003-09-22 University Of Delaware Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
ES2338111T3 (es) 2002-08-21 2010-05-04 Revivicor, Inc. Animales porcinos que carecen de cualquier expresion de alfa 1,3 galactosiltransferasa funcional.
JP2006505291A (ja) 2002-11-08 2006-02-16 ヘマテック，エルエルシー プリオンタンパク質活性が低減されたトランスジェニック有蹄動物及びその用途
WO2004078971A1 (ja) 2003-03-06 2004-09-16 Toudai Tlo, Ltd. ゲノムｄｎａの標的メチル化領域の脱メチル化法
CA2528500A1 (en) 2003-06-06 2004-12-16 University Of Pittsburgh Porcine cmp-n-acetylneuraminic acid hydroxylase gene
US7560538B2 (en) 2003-11-05 2009-07-14 University Of Pittsburgh Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region
DK1734814T3 (en) 2004-03-17 2015-04-07 Revivicor Inc Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase
CA2563064A1 (en) 2004-04-22 2005-11-10 Kirin Beer Kabushiki Kaisha Transgenic animals and uses thereof
WO2005111204A2 (en) 2004-05-07 2005-11-24 University Of Pittsburgh Of The Commonwealth System Of Higher Education Porcine forssman synthetase cdna and polypeptide
NZ554824A (en) 2004-10-22 2010-10-29 Revivicor Inc Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
US20080026457A1 (en) 2004-10-22 2008-01-31 Kevin Wells Ungulates with genetically modified immune systems
US20090186097A1 (en) 2005-08-09 2009-07-23 David Lee Ayares Transgenic Ungulates Expressing CTLA4-IG and Uses Thereof
CA2648718A1 (en) 2006-04-07 2007-10-18 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
WO2007147167A2 (en) 2006-06-16 2007-12-21 Porous Power Technologies, Llc Optimized microporous structure of electrochemical cells
JP5327733B2 (ja) * 2007-09-18 2013-10-30 国立大学法人名古屋大学 魚類胚の作製方法及びその利用
DK2348827T3 (en) 2008-10-27 2015-07-20 Revivicor Inc IMMUNICIPLY COMPROMATED PETS
US9276246B2 (en) 2009-05-20 2016-03-01 Samsung Electronics Co., Ltd. Treatment and adhesive for microporous membranes
KR101236724B1 (ko) 2010-11-23 2013-02-26 대한민국 단백질 과발현 카세트를 포함하는 유전자 타겟팅 넉인 벡터, 이의 제조 방법 및 이 벡터가 도입된 이종간 이식용 형질전환 복제동물
CA2827348C (en) 2011-02-14 2021-02-23 Revivicor, Inc. Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
CN117279502A (zh) 2020-11-20 2023-12-22 雷维维科公司 用于异种移植的生长激素受体敲除的多转基因猪
EP4404740A1 (de) 2021-09-20 2024-07-31 Revivicor Inc. Multitransgene schweine mit zehn genetischen modifikationen zur xenotransplantation
JP2023131904A (ja) * 2022-03-10 2023-09-22 国立大学法人愛媛大学 細胞の移植方法
AU2024296897A1 (en) 2023-07-07 2026-02-19 Technische Universitaet Muenchen, In Vertretung Des Freistaates Bayern Transgenic pig comprising a transgene for xenotransplantation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2126606T3 (es) * 1991-11-15 1999-04-01 Univ California Terapia del sistema nervioso central mediante celulas modificadas geneticamente.
AU697234B2 (en) * 1993-06-23 1998-10-01 Viventia Biotech Inc. Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US5994619A (en) 1996-04-01 1999-11-30 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Production of chimeric bovine or porcine animals using cultured inner cell mass cells
US5905042A (en) 1996-04-01 1999-05-18 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Cultured inner cell mass cell lines derived from bovine or porcine embryos
WO1997038710A1 (en) * 1996-04-12 1997-10-23 Fibrogen, Inc. Synthesis of human procollagens and collagens in recombinant dna systems
JP2001500725A (ja) 1996-08-19 2001-01-23 ユニヴァーシティー オヴ マサチューセッツ 種間核移植により製造される胚性または幹細胞様細胞株
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
JPH10146193A (ja) * 1996-09-23 1998-06-02 Chihiro Koike 相同組換え用ｄｎａコンストラクト、このコンストラクトを用いた形質転換体の選別方法及び相同組換え法
US6235969B1 (en) 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
AU743305C (en) * 1997-01-17 2006-03-30 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
GB9703550D0 (en) * 1997-02-20 1997-04-09 Ppl Therapeutics Scotland Ltd Cell mediated transgenesis
JP2002512510A (ja) 1997-03-06 2002-04-23 インフィジェン・インコーポレーテッド 動物のクローニング方法
US6504081B1 (en) * 1997-06-13 2003-01-07 President And Fellow Of Harvard College Methods and uses for transposon-based gene targeting
JP2001509361A (ja) 1997-07-03 2001-07-24 ユニヴァーシティー オヴ マサチューセッツ 分化した無血清飢餓細胞からの供与核を用いるクローニング
GB9715064D0 (en) 1997-07-17 1997-09-24 Ppl Therapeutics Scotland Ltd Protein expression

Also Published As

Publication number Publication date
DE60043578D1 (de) 2010-02-04
NZ514620A (en) 2004-04-30
AU2926700A (en) 2000-09-21
EP2199392A2 (de) 2010-06-23
CA2361943A1 (en) 2000-09-08
ES2338631T3 (es) 2010-05-11
JP2011188873A (ja) 2011-09-29
CA2361943C (en) 2011-05-17
WO2000051424A2 (en) 2000-09-08
PT1159415E (pt) 2010-03-31
EP1159415A2 (de) 2001-12-05
AU780754B2 (en) 2005-04-14
EP2199392A3 (de) 2010-12-15
EP1159415B1 (de) 2009-12-23
JP2002537785A (ja) 2002-11-12
DK1159415T3 (da) 2010-05-03
WO2000051424A3 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
DE60043578D1 (de) Genetische veränderung von somatischen zellen und deren verwendungen
ES2626025T3 (es) Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
Zhou et al. Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer
Zhou et al. Efficient generation of gene‐modified pigs harboring precise orthologous human mutation via CRISPR/Cas9‐induced homology‐directed repair in zygotes
Inoue et al. Effects of donor cell type and genotype on the efficiency of mouse somatic cell cloning
DE60236182D1 (de) Zufällige integration von polynukleotide nach in vivo linearisierung
GB2432846B (en) Medium and culture of embryonic stem cells
BR0209989A (pt) Plataformas baseadas em cromossomas
DE60231708D1 (de) Somatische pluripotente Zellen
US20160208214A1 (en) Methods and compositions for generation of developmentally-incompetent eggs in recipients of nuclear genetic transfer
ATE381614T1 (de) Bildung von xenogenen antikörpern
EA200501774A1 (ru) Культуры e1-иммортализованных клеток и способы их культивирования с целью повышения выхода их продукции
BR0214366A (pt) construção de ácido nucleico recombinante, célula e, métodos para produzir ácido láctico, e para reduzir a atividade de piruvato descarboxilase em uma célula
CN104611368A (zh) 重组后不产生移码突变的载体、在爪蛙基因组中进行基因定点敲入的方法及应用
DE60041055D1 (de) Kombinierte verwendung von mittelkettige fettsäuren enthaltenden triglyceriden und exogenen lipolytischen enzymen als tierfutterzusatzstoffe
ATE407203T1 (de) Doppelkerntransfersverfahren und dessen ergebnisse
RU2006146795A (ru) Композиция для стимулирования роста и регенерации клеток, а также способы ее получения
DE69935907D1 (de) Hocheffizienzverfahren und zusammensetzungen zum integrieren von exogener dna in genomische sperma-dna
ATE243741T1 (de) Zufuhr von genprodukten mittels mesangium-zellen
Katona De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications
Kouprina et al. Recent advances in chromosome engineering
ES2074560T3 (es) Procedimiento para la produccion de un animal transgenico no humano mediante la introduccion de adn exogeno en celulas animales somaticas y germinales.
Gim et al. Transgenic F2 bovine embryos show stable germline transmission and maintenance of transgene expression through two generations
ATE268182T1 (de) Transplantations/implantatsvorrichtung und ihre herstellungsmethode
Chun et al. Genome editing and induced pluripotent stem cell technologies for personalized study of cardiovascular diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159415

Country of ref document: EP